📰 Dexcom News
Page 102 - Dexcom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dexcom. Real-time updates on events, politics, business and more.
August 1, 2023
DexCom (NASDAQ:DXCM – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Monday. Several other brokerages also recently issued reports on DXCM. Barclays upped their target price on shares of DexCom from $115.00 to $138.00 and gave the stock an “equal […]
August 1, 2023
Raymond James Trust N.A. cut its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.4% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,640 shares of the medical device company’s stock after selling 318 shares during the period. […]
July 31, 2023
Emerald Advisers LLC trimmed its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 52.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,212 shares of the medical device company’s stock after selling 2,452 shares during the period. […]
July 31, 2023
Beacon Investment Advisory Services Inc. lifted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 0.1% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 741,712 shares of the medical device company’s stock after acquiring an additional 1,053 shares during the quarter. DexCom […]
July 30, 2023
DexCom (NASDAQ:DXCM – Get Free Report) had its price objective boosted by analysts at Robert W. Baird from $145.00 to $153.00 in a report issued on Friday, FlyOnTheWall reports. Robert W. Baird’s target price indicates a potential upside of 15.58% from the stock’s current price. Several other research analysts have also recently issued reports on […]
July 29, 2023
NorthRock Partners LLC lessened its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the first quarter, HoldingsChannel reports. The fund owned 3,538 shares of the medical device company’s stock after selling 499 shares during the quarter. NorthRock Partners LLC’s holdings in DexCom were worth $411,000 as of its most recent SEC filing. […]
July 29, 2023
DexCom (NASDAQ:DXCM – Free Report) had its price target lifted by Robert W. Baird from $145.00 to $153.00 in a research note issued to investors on Friday, FlyOnTheWall reports. DXCM has been the subject of a number of other research reports. Citigroup raised their target price on shares of DexCom from $146.00 to $150.00 in […]
July 29, 2023
For only $21 a month. go to select, quote, rt.com now (f your family needs at a priceemal expa. >> selectquote we shop. you save attention. you save attention. medicare coverage for people with diabetes. diabetes. if you have diabetes getting on dexcom g7 is the single most . eliminates painful finger sticks, helps lower agency and ise announ covered by medicu before using the dexcom g7, i was really frustratel d. >> but you wont see a stuck dexcom g7 sensor glucose numbers to your phone or dexc...
July 29, 2023
DexCom (NASDAQ:DXCM – Free Report) had its price target upped by Raymond James from $140.00 to $154.00 in a research report report published on Friday, FlyOnTheWall reports. Other equities research analysts also recently issued research reports about the company. BTIG Research raised their price target on DexCom from $134.00 to $150.00 in a research report […]
July 29, 2023
Tilt Investment Management Holdings PBC raised its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 14.6% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,048 shares of the medical device company’s stock after acquiring an additional 261 shares during the quarter. Tilt Investment […]